Broad Institute

AUGUST 7, 2024

At the Broad, he directs the Cancer Genome Computational Analysis Group , and he is a professor of pathology at Harvard Medical School and director of bioinformatics at Massachusetts General Hospital. He is also an associate professor of psychiatry at Massachusetts General Hospital and Harvard Medical School.

Medical Schools 90

Medical Schools Hospitals Bioinformatics Vaccine 90

Drug Target Review

DECEMBER 28, 2023

Recent advances in bioinformatics show clonal neoantigens are the best targets for immunotherapy, as I will elucidate below. Using powerful bioinformatics technology developed and validated with sequence data from the TRACERx study, researchers are able to identify clonal neoantigens from a patient’s unique tumour profile.

Bioinformatics 105

Bioinformatics Immune Response DNA Vaccine 105

Broad Institute

JULY 10, 2023

Alicia Martin and attendees of the KEMRI-Wellcome Trust/GINGER Bioinformatics training in Kilifi, Kenya in September 2018. Chan School of Public Health that trains scientists to conduct analyses within their home communities in East and South Africa. Martin felt at home in his lab right away. “It

Disease 98

Disease Bioinformatics Medical Schools Research 98

Broad Institute

AUGUST 4, 2022

Patients’ clinical outcomes were associated with a combination of genomic, transcriptomic, and epigenomic features — so that integrating these data could predict a patient’s likelihood of experiencing remission versus developing more advanced cancer.

Bioinformatics 52

Bioinformatics Medical Schools Hospitals Treatment 52

Broad Institute

APRIL 25, 2024

The Sentinel team has also trained more than 1,600 scientists from all 54 African countries in genomics, diagnostics, and bioinformatics. Ozonoff is also an associate professor of pediatrics at Harvard Medical School and a scientist at Boston Children’s Hospital.

Virus 132

Virus Hospitals Disease Government 132

DrugBank

FEBRUARY 12, 2025

In Silico Drug Repurposing Advances in bioinformatics and systems biology have fueled the rise of repurposing of in silico drugs. For example, researchers at Harvard Medical School explored the association between the use of anti-inflammatory medications and the risk of developing Parkinson's disease.

Cell Based Assays 52

Cell Based Assays Drugs Pharmacokinetics Disease 52